REFERENCES
1. McCormick WF. The pathology of vascular ("arteriovenous") malformations. J Neurosurg 1966;24:807-16.
3. Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system (4th edition). Am J Surg Pathol 1978;2:113.
4. Otten P, Pizzolato GP, Rilliet B, Berney J. 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie ;35:82-131. (in French).
5. Voigt K, Yaşargil MG. Cerebral cavernous haemangiomas or cavernomas. Incidence, pathology, localization, diagnosis, clinical features and treatment. Review of the literature and report of an unusual case. Neurochirurgia (Stuttg) 1976;19:59-68.
6. Giombini S, Morello G. Cavernous angiomas of the brain. Account of fourteen personal cases and review of the literature. Acta Neurochir (Wien) 1978;40:61-82.
7. Savoiardo M, Strada L, Passerini A. Intracranial cavernous hemangiomas: neuroradiologic review of 36 operated cases. Am J Neuroradiol 1983;4:945-50.
9. Bruhlmann Y, De Tribolet N, Berney J. Les angiomes caverneux intracérébraux. Neurochirurgie 1985;31:271-9. (in French).
10. Simard JM, Garcia-Bengochea F, Ballinger WE Jr, Mickle JP, Quisling RG. Cavernous angioma: a review of 126 collected and 12 new clinical cases. Neurosurgery 1986;18:162-72.
11. Tagle P, Huete I, Méndez J, del Villar S. Intracranial cavernous angioma: presentation and management. J Neurosurg 1986;64:720-3.
12. Salman RA, Hall JM, Horne MA, et al. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol 2012;11:217-24.
13. Radvany MG, Rigamonti D, Gailloud P. Angiographic detection of cerebral cavernous malformations with C-arm cone beam CT imaging in three patients. J Neurointerv Surg 2014;6:e17.
14. Bell BA, Kendall BE, Symon L. Angiographically occult arteriovenous malformations of the brain. J Neurol Neurosurg Psychiatry 1978;41:1057-64.
15. Becker DH, Townsend JJ, Kramer RA, Newton TH. Occult cerebrovascular malformations. A series of 18 histologically verified cases with negative angiography. Brain 1979;102:249-87.
16. Sadeh M, Shacked I, Rappaport Z, Tadmor R. Surgical extirpation of a venous angioma of the medulla oblongata simulating multiple sclerosis. Surg Neurol 1982;17:334-7.
17. Senegor M, Dohrmann GJ, Wollmann RL. Venous angiomas of the posterior fossa should be considered as anomalous venous drainage. Surg Neurol 1983;19:26-32.
18. Hayman LA, Evans RA, Ferrell RE, Fahr LM, Ostrow P, Riccardi VM. Familial cavernous angiomas: natural history and genetic study over a 5-year period. Am J Med Genet 1982;11:147-60.
19. Rigamonti D, Drayer BP, Johnson PC, Hadley MN, Zabramski J, Spetzler RF. The MRI appearance of cavernous malformations (angiomas). J Neurosurg 1987;67:518-24.
20. Morris Z, Whiteley WN, Longstreth WT Jr, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009;339:b3016.
21. Flemming KD. Incidence, prevalence, and clinical presentation of cerebral cavernous malformations. Methods Mol Biol 2020;2152:27-33.
22. Rigamonti D, Spetzler RF. The association of venous and cavernous malformations. Report of four cases and discussion of the pathophysiological, diagnostic, and therapeutic implications. Acta Neurochir (Wien) 1988;92:100-5.
23. Rigamonti D, Pappas CT, Spetzler RF, Johnson PC. Extracerebral cavernous angiomas of the middle fossa. Neurosurgery 1990;27:306-10.
24. Smith ER, Michael Scott R, Rigamonti D. Surgical treatment of cavernous malformations in children. In: Rigamonti D, editor. Cavernous malformations of the nervous system. Cambridge: Cambridge University Press; 2011. p. 135-42.
25. Rigamonti D, Spetzler RF, Drayer BP, et al. Appearance of venous malformations on magnetic resonance imaging. J Neurosurg 1988;69:535-9.
26. Rigamonti D, Spetzler RF, Medina M, Rigamonti K, Geckle DS, Pappas C. Cerebral venous malformations. J Neurosurg 1990;73:560-4.
27. Rigamonti D, Johnson PC, Spetzler RF, Hadley MN, Drayer BP. Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. Neurosurgery 1991;28:60-4.
28. Lee RR, Becher MW, Benson ML, Rigamonti D. Brain capillary telangiectasia: MR imaging appearance and clinicohistopathologic findings. Radiology 1997;205:797-805.
29. Naff NJ, Wemmer J, Hoenig-Rigamonti K, Rigamonti DR. A longitudinal study of patients with venous malformations: documentation of a negligible hemorrhage risk and benign natural history. Neurology 1998;50:1709-14.
30. Clatterbuck RE, Moriarity JL, Elmaci I, Lee RR, Breiter SN, Rigamonti D. Dynamic nature of cavernous malformations: a prospective magnetic resonance imaging study with volumetric analysis. J Neurosurg 2000;93:981-6.
31. Moriarity JL, Clatterbuck RE, Rigamonti D. The natural history of cavernous malformations. Neurosurg Clin N Am 1999;10:411-7.
32. Moriarity JL, Wetzel M, Clatterbuck RE, et al. The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery 1999;44:1166-71.
33. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 2001;71:188-92.
34. Clatterbuck RE, Elmaci I, Rigamonti D. The nature and fate of punctate (Type IV) cavernous malformations. Neurosurgery 2001;49:26-32.
35. Kharkar S, Shuck J, Conway J, Rigamonti D. The natural history of conservatively managed symptomatic intramedullary spinal cord cavernomas. Neurosurgery 2007;60:865-72; discussion 865.
36. Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol 2009;5:659-70.
37. Zabramski JM, Wascher TM, Spetzler RF, et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422-32.
38. Souza JM, Domingues RC, Cruz LC Jr, Domingues FS, Iasbeck T, Gasparetto EL. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with t2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol 2008;29:154-8.
39. Rivera PP, Willinsky RA, Porter PJ. Intracranial cavernous malformations. Neuroimaging Clin N Am 2003;13:27-40.
40. Li KW, Haroun RI, Clatterbuck RE, Murphy K, Rigamonti D. Superficial siderosis associated with multiple cavernous malformations: report of three cases. Neurosurgery 2001;48:1147-51.
41. Beechar VB, Srinivasan VM, Reznik OE, et al. Intraventricular cavernomas of the third ventricle: report of 2 cases and a systematic review of the literature. World Neurosurg 2017;105:935-943.e3.
42. Detwiler PW, Porter RW, Zabramski JM, Spetzler RF. De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage. Case report and review of the literature. J Neurosurg 1997;87:629-32.
43. Nimjee SM, Powers CJ, Bulsara KR. Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy. Neurosurg Focus 2006;21:e4.
44. Rosenblum JS, Nazari M, Al-Khalili Y, Potigailo V, Veznedaroglu E. Unilateral symptomatic hypertrophic olivary degeneration secondary to midline brainstem cavernous angioma: a case report and review of the literature. World Neurosurg 2018;110:294-300.
45. Rigamonti D, Hadley MN, Drayer BP, et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 1988;319:343-7.
46. Flemming KD, Bovis GK, Meyer FB. Aggressive course of multiple de novo cavernous malformations. J Neurosurg 2011;115:1175-8.
47. Gastelum E, Sear K, Hills N, et al. Rates and characteristics of radiographically detected intracerebral cavernous malformations after cranial radiation therapy in pediatric cancer patients. J Child Neurol 2015;30:842-9.
48. Clatterbuck RE, Elmací I, Rigamonti D. The juxtaposition of a capillary telangiectasia, cavernous malformation, and developmental venous anomaly in the brainstem of a single patient: case report. Neurosurgery 2001;49:1246-50.
49. Clatterbuck RE, Cohen B, Gailloud P, Murphy K, Rigamonti D. Vertebral hemangiomas associated with familial cerebral cavernous malformation: segmental disease expression. Case report. J Neurosurg 2002;97:227-30.
50. Polymeropoulos MH, Hurko O, Hsu F, et al. Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descent. Neurology 1997;48:752-7.
51. Zhang J, Clatterbuck RE, Rigamonti D, Dietz HC. Mutations in KRIT1 in familial cerebral cavernous malformations. Neurosurgery 2000;46:1272-7; discussion 1277.
52. Zhang J, Clatterbuck RE, Rigamonti D, Dietz HC. Cloning of the murine Krit1 cDNA reveals novel mammalian 5' coding exons. Genomics 2000;70:392-5.
53. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC. Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 2001;10:2953-60.
54. Zhang J, Rigamonti D, Dietz HC, Clatterbuck RE. Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations. Neurosurgery 2007;60:353-9; discussion 359.
55. Zhang J, Basu S, Rigamonti D, Dietz HC, Clatterbuck RE. Krit1 modulates beta 1-integrin-mediated endothelial cell proliferation. Neurosurgery 2008;63:571-8; discussion 578.
56. Liu H, Rigamonti D, Badr A, Zhang J. Ccm1 assures microvascular integrity during angiogenesis. Trans Stroke Res 2010;1:146-53.
57. Zhang J, Carr CW, Rigamonti D, Badr A. Genome-wide linkage scan maps ETINPH gene to chromosome 19q12-13.31. Hum Hered 2010;69:262-7.
58. Liu H, Rigamonti D, Badr A, Zhang J. Ccm1 regulates microvascular morphogenesis during angiogenesis. J Vasc Res 2011;48:130-40.
59. Bergametti F, Denier C, Labauge P, et al. Société Française de Neurochirurgie. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 2005;76:42-51.
60. Denier C, Labauge P, Bergametti F, et al. Société Française de Neurochirurgie. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol 2006;60:550-6.
61. Spiegler S, Rath M, Paperlein C, Felbor U. Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling. Mol Syndromol 2018;9:60-9.
62. Stenson PD, Mort M, Ball EV, et al. The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research setting. Hum Genet 2020;139:1197-207.
63. Corr M, Lerman I, Keubel JM, et al. Decreased Krev interaction-trapped 1 expression leads to increased vascular permeability and modifies inflammatory responses in vivo. Arterioscler Thromb Vasc Biol 2012;32:2702-10.
64. Draheim KM, Fisher OS, Boggon TJ, Calderwood DA. Cerebral cavernous malformation proteins at a glance. J Cell Sci 2014;127:701-7.
65. Fisher OS, Boggon TJ. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology. Cell Mol Life Sci 2014;71:1881-92.
66. Draheim KM, Li X, Zhang R, et al. CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation. J Cell Biol 2015;208:987-1001.
67. Shenkar R, Shi C, Rebeiz T, et al. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med 2015;17:188-96.
68. Jenny Zhou H, Qin L, Zhang H, et al. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nat Med 2016;22:1033-42.
69. Vos IJ, Vreeburg M, Koek GH, van Steensel MA. Review of familial cerebral cavernous malformations and report of seven additional families. Am J Med Genet A 2017;173:338-51.
70. Abou-Fadel J, Qu Y, Gonzalez EM, Smith M, Zhang J. Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers. Oncol Rep 2020;43:1945-63.
71. Orsenigo F, Conze LL, Jauhiainen S, et al. Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution. Elife 2020;9:e61413.
72. Peng W, Wu X, Feng D, et al. Cerebral cavernous malformation 3 relieves subarachnoid hemorrhage-induced neuroinflammation in rats through inhibiting NF-kB signaling pathway. Brain Res Bull 2020;160:74-84.
73. Su VL, Calderwood DA. Signalling through cerebral cavernous malformation protein networks. Open Biol 2020;10:200263.
74. Wei S, Li Y, Polster SP, Weber CR, Awad IA, Shen L. Cerebral cavernous malformation proteins in barrier maintenance and regulation. Int J Mol Sci 2020;21:675.
75. Ricci C, Cerase A, Riolo G, Manasse G, Battistini S. KRIT1 gene in patients with cerebral cavernous malformations: clinical features and molecular characterization of novel variants. J Mol Neurosci 2021; doi: 10.1007/s12031-021-01814-w.
76. Riolo G, Ricci C, Battistini S. Molecular genetic features of cerebral cavernous malformations (CCM) Patients: an overall view from genes to endothelial cells. Cells 2021;10:704.
77. Cuttano R, Rudini N, Bravi L, et al. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med 2016;8:6-24.
78. Padarti A, Zhang J. Recent advances in cerebral cavernous malformation research. Vessel Plus 2018;2:21.
79. Abou-Fadel J, Vasquez M, Grajeda B, Ellis C, Zhang J. Systems-wide analysis unravels the new roles of CCM signal complex (CSC). Heliyon 2019;5:e02899.
80. Jiang X, Padarti A, Qu Y, et al. Alternatively spliced isoforms reveal a novel type of PTB domain in CCM2 protein. Sci Rep 2019;9:15808.
81. Awad IA, Polster SP. Cavernous angiomas: deconstructing a neurosurgical disease. J Neurosurg 2019;131:1-13.
82. De Luca E, Pedone D, Moglianetti M, et al. Multifunctional platinum@BSA-rapamycin nanocarriers for the combinatorial therapy of cerebral cavernous malformation. ACS Omega 2018;3:15389-98.
83. Marchi S, Corricelli M, Trapani E, et al. Defective autophagy is a key feature of cerebral cavernous malformations. EMBO Mol Med 2015;7:1403-17.
84. Ren AA, Snellings DA, Su YS, et al. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature 2021;594:271-6.
85. Akers A, Al-Shahi Salman R, A Awad I, et al. Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery 2017;80:665-80.
